Butylated Hydroxyanisole (BHA) CAS # 25013-16-5 Pharmaceutical excipients White to slightly yellow waxy flakes/powder with characteristic odour

Description des marchandises

IEBTI21NT-14-1057-DEC

Expiré

Pays émetteur

Date d'émission

5 mars 2021

Valide à partir du

5 mars 2021

Valide jusqu'au

4 mars 2024

Lieu d'émission

NENAGH, CO.TIPPERARY, IRELAND

Butylated Hydroxyanisole (BHA) CAS # 25013-16-5 Pharmaceutical excipients White to slightly yellow waxy flakes/powder with characteristic odour

GENERAL INTERPRETIVE RULES 1 & 6 HSEN TO CHAPTER 29 TEXT TO CODES 2909, 2909 50, 2909 50 00 90 ECICS

AS FLAKESAS POWDERFOR PHARMACEUTICAL INDUSTRYFOR PHARMACEUTICALSIN SOLID FORMPHARMACEUTICAL PRODUCTSWHITEYELLOW

Description des marchandises

Butylated Hydroxyanisole (BHA) CAS # 25013-16-5 Pharmaceutical excipients White to slightly yellow waxy flakes/powder with characteristic odour

Expiré

Pays émetteur

Date d'émission

5 mars 2021

Valide à partir du

5 mars 2021

Valide jusqu'au

4 mars 2024

Lieu d'émission

NENAGH, CO.TIPPERARY, IRELAND

Butylated Hydroxyanisole (BHA) CAS # 25013-16-5 Pharmaceutical excipients White to slightly yellow waxy flakes/powder with characteristic odour

GENERAL INTERPRETIVE RULES 1 & 6 HSEN TO CHAPTER 29 TEXT TO CODES 2909, 2909 50, 2909 50 00 90 ECICS

AS FLAKESAS POWDERFOR PHARMACEUTICAL INDUSTRYFOR PHARMACEUTICALSIN SOLID FORMPHARMACEUTICAL PRODUCTSWHITEYELLOW